Patent intelligence · IT
IT 202200024963
Composti attivatori dei canali potassio Kv7.2/Kv7.3
Composti attivatori dei canali potassio Kv7.2/Kv7.3
Patent details — IT 202200024963
- Jurisdiction
- IT
- Status
- granted
- Grant date
- Jun 5, 2024
- Expiration
- May 31, 2044
- Applicant
- ANGELINI PHARMA S P A [IT]
- CPC classes
- A61K/3144, A61P/2500
Quick answer
IT 202200024963 (Composti attivatori dei canali potassio Kv7.2/Kv7.3) is held by ANGELINI PHARMA S P A [IT]. Status: granted. Granted Jun 5, 2024. Expires May 31, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ANGELINI PHARMA S P A [IT]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K/3144, A61P/2500
More from ANGELINI PHARMA S P A [IT]
Related pharmaceutical patents in our USPTO index.
-
WO 2025252600
COMPOSÉS ACTIVATEURS DE CANAUX POTASSIQUES KV7.2/KV7.3
granted -
WO 2025252599
COMPOSÉS ACTIVATEURS DE CANAUX POTASSIQUES KV7.2/KV7.3
granted -
AU 2024268154
NOVEL CARBOXAMIDE DERIVATIVES
granted -
IT 202300027246
Matrici farmaceutiche per il rilascio prolungato di farmaci
granted -
IT 202200024948
Composti attivatori dei canali potassio KV7.2/KV7.3
granted -
AU 2022390453
NOVEL HETEROARYL-UREA COMPOUNDS AS KV7.2 INHIBITORS
granted
Frequently asked questions
What is US patent 202200024963?
IT 202200024963 (Composti attivatori dei canali potassio Kv7.2/Kv7.3) is held by ANGELINI PHARMA S P A [IT]. Status: granted. Granted Jun 5, 2024. Expires May 31, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns IT 202200024963?
ANGELINI PHARMA S P A [IT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 7 pharmaceutical patents for this assignee.
When does IT 202200024963 expire?
Our index shows an expiration date of May 31, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.